Eli Lilly and Company
PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF PSORIASIS AND SYSTEMIC LUPUS ERYTHEMATOSUS
Last updated:
Abstract:
The present invention provides a compound of Formula I: wherein R is methyl or ethyl; or a pharmaceutically acceptable salt thereof useful for treating psoriasis or systemic lupus erythematosus. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
4 Sep 2019
Issue date:
24 Jun 2021